Abstract
Acral lentiginous melanoma (ALM) is a rare subtype of melanoma mainly arising on the palms, soles, and nail beds. ALM is the most common subtype of melanoma found in patients of Asian or African descent and tends to more advanced at presentation due to delays in diagnosis. Surgical treatment is difficult owing to the complexity and functional importance of the hands and feet and reconstruction after resection is usually needed. The prognosis for patients with ALM depends on stage of disease and tends to be worse than with other subtypes of melanoma. Newer treatment modalities such as immunotherapies and targeted agents are being tested in patients with advanced ALM with some promising preliminary results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bradford PT, Goldstein AM, McMaster ML, Tucker MA (2009) Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986–2005. Arch Dermatol 145:427–434. doi:10.1001/archdermatol.2008.609
Piliang MP (2011) Acral lentiginous melanoma. Clin Lab Med 31:281–288. doi:10.1016/j.cll.2011.03.005
Zell JA et al (2008) Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol Official J Am Soc Clin Oncol 26:66–75. doi:10.1200/JCO.2007.12.3604
Zebary A et al (2013) KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. J Dermatol Sci 72:284–289. doi:10.1016/j.jdermsci.2013.07.013
Nagore E, Pereda C, Botella-Estrada R, Requena C, Guillen C (2009) Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility. Cancer Causes Control CCC 20:115–119. doi:10.1007/s10552-008-9221-y
Soon SL et al (2003) Acral lentiginous melanoma mimicking benign disease: the Emory experience. J Am Acad Dermatol 48:183–188. doi:10.1067/mjd.2003.63
Stubblefield J, Kelly B (2014) Melanoma in non-caucasian populations. Surg Clin North Am 94:1115–1126, ix. doi:10.1016/j.suc.2014.07.008
Durbec F, Martin L, Derancourt C, Grange F (2012) Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol 166:727–739. doi:10.1111/j.1365-2133.2011.10772.x
Perrin C, Michiels JF, Pisani A, Ortonne JP (1997) Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. Am J Dermatopathol 19:462–467
Bastian BC (2014) The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Ann Rev Pathol 9:239–271. doi:10.1146/annurev-pathol-012513-104658
Bennett DC (2008) How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21:27–38. doi:10.1111/j.1755-148X.2007.00433.x
Egger ME et al (2012) Unique prognostic factors in acral lentiginous melanoma. Am J Surg 204:874–879; discussion 879–880. doi:10.1016/j.amjsurg.2012.05.013
Evans GR, Friedman J, Shenaq J, Mosser S (1997) Plantar flap reconstruction for acral lentiginous melanoma. Ann Surg Oncol 4:575–578
Savarese I et al (2014) Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. Clin Exp Dermatol. doi:10.1111/ced.12469
Sue GR, Hanlon A, Lazova R, Narayan D (2014) Use of imiquimod for residual acral melanoma. BMJ Case Report. doi:10.1136/bcr-2014-203826
Sureda N et al (2011) Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review. Br J Dermatol 165:852–858. doi:10.1111/j.1365-2133.2011.10477.x
Goitz RJ, Westkaemper JG, Tomaino MM, Sotereanos DG (1997) Soft-tissue defects of the digits. Coverage considerations. Hand Clin 13:189–205
Atasoy E, Ioakimidis E, Kasdan ML, Kutz JE, Kleinert HE (1970) Reconstruction of the amputated finger tip with a triangular volar flap. A new surgical procedure. J Bone Joint Surg 52:921–926
Curtis RM (1957) Cross-finger pedicle flap in hand surgery. Ann Surg 145:650–655
Gokrem S, Tuncali D, Terzioglu A, Toksoy K, Aslan G (2007) The thin cross finger skin flap. J Hand Surg Eur 32:417–420. doi:10.1016/j.jhsb.2007.02.010
Chen HC, Buchman MT, Wei FC (1999) Free flaps for soft tissue coverage in the hand and fingers. Hand Clin 15:541–554
O’Neill PJ, Litts C (2004) Hand and forearm reconstruction after skin cancer ablation. Clin Plast Surg 31:113–119
Miller DM, Flaherty KT, Tsao H (2014) Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma. Semin Cutan Med Surg 33:60–67
Naidoo J, Page DB, Wolchok JD (2014) Immune modulation for cancer therapy. Br J Cancer 111:2214–2219. doi:10.1038/bjc.2014.348
Hodi FS et al (2013) Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol Official J Am Soc Clin Oncol 31:3182–3190. doi:10.1200/JCO.2012.47.7836
Minor DR et al (2012) Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res Official J Am Assoc Cancer Res 18:1457–1463. doi:10.1158/1078-0432.CCR-11-1987
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Goydos, J.S., Shoen, S.L. (2016). Acral Lentiginous Melanoma. In: Kaufman, H., Mehnert, J. (eds) Melanoma. Cancer Treatment and Research, vol 167. Springer, Cham. https://doi.org/10.1007/978-3-319-22539-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-22539-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22538-8
Online ISBN: 978-3-319-22539-5
eBook Packages: MedicineMedicine (R0)